X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB BIOCON LTD UNICHEM LAB/
BIOCON LTD
 
P/E (TTM) x 22.0 37.1 59.2% View Chart
P/BV x 2.3 4.9 46.9% View Chart
Dividend Yield % 0.8 1.5 54.8%  

Financials

 UNICHEM LAB   BIOCON LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
BIOCON LTD
Mar-16
UNICHEM LAB/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs334496 67.4%   
Low Rs174397 43.9%   
Sales per share (Unadj.) Rs146.9174.3 84.3%  
Earnings per share (Unadj.) Rs11.944.8 26.5%  
Cash flow per share (Unadj.) Rs16.256.9 28.4%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.81.1 70.3%  
Book value per share (Unadj.) Rs105.1202.8 51.8%  
Shares outstanding (eoy) m90.84200.00 45.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.72.6 67.5%   
Avg P/E ratio x21.410.0 214.5%  
P/CF ratio (eoy) x15.77.8 200.2%  
Price / Book Value ratio x2.42.2 109.8%  
Dividend payout %16.811.2 150.7%   
Avg Mkt Cap Rs m23,07389,220 25.9%   
No. of employees `0005.74.4 128.5%   
Total wages/salary Rs m2,5586,363 40.2%   
Avg. sales/employee Rs Th2,352.57,894.5 29.8%   
Avg. wages/employee Rs Th450.91,441.2 31.3%   
Avg. net profit/employee Rs Th190.42,029.7 9.4%   
INCOME DATA
Net Sales Rs m13,34634,854 38.3%  
Other income Rs m192845 22.7%   
Total revenues Rs m13,53835,699 37.9%   
Gross profit Rs m1,6398,200 20.0%  
Depreciation Rs m3902,423 16.1%   
Interest Rs m29102 28.2%   
Profit before tax Rs m1,4126,520 21.7%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-355,754 -0.6%   
Tax Rs m2932,569 11.4%   
Profit after tax Rs m1,0808,961 12.1%  
Gross profit margin %12.323.5 52.2%  
Effective tax rate %20.739.4 52.6%   
Net profit margin %8.125.7 31.5%  
BALANCE SHEET DATA
Current assets Rs m5,97939,932 15.0%   
Current liabilities Rs m2,43216,276 14.9%   
Net working cap to sales %26.667.9 39.2%  
Current ratio x2.52.5 100.2%  
Inventory Days Days6354 117.7%  
Debtors Days Days6086 70.1%  
Net fixed assets Rs m6,40339,101 16.4%   
Share capital Rs m1821,000 18.2%   
"Free" reserves Rs m9,29338,591 24.1%   
Net worth Rs m9,54840,556 23.5%   
Long term debt Rs m23020,724 1.1%   
Total assets Rs m12,84384,816 15.1%  
Interest coverage x50.064.9 77.1%   
Debt to equity ratio x00.5 4.7%  
Sales to assets ratio x1.00.4 252.9%   
Return on assets %8.610.7 80.8%  
Return on equity %11.322.1 51.2%  
Return on capital %14.319.0 75.5%  
Exports to sales %29.230.7 95.0%   
Imports to sales %6.320.4 31.1%   
Exports (fob) Rs m3,90010,717 36.4%   
Imports (cif) Rs m8477,105 11.9%   
Fx inflow Rs m4,35611,789 37.0%   
Fx outflow Rs m1,1628,393 13.8%   
Net fx Rs m3,1943,396 94.1%   
CASH FLOW
From Operations Rs m1,1195,264 21.3%  
From Investments Rs m-853-9,540 8.9%  
From Financial Activity Rs m-33410,867 -3.1%  
Net Cashflow Rs m-686,591 -1.0%  

Share Holding

Indian Promoters % 50.1 40.4 124.0%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 15.1 8.4 179.8%  
FIIs % 3.0 10.7 28.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 19.9 159.3%  
Shareholders   20,176 109,995 18.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STRIDES SHASUN LTD  ELDER PHARMA  SUVEN LIFE  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 24, 2017 10:25 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS